A Phase 1b Study of WU-NK-101 in Combination With Cetuximab
A Phase 1b Study of WU-NK-101 in Combination With Cetuximab
Active, not recruiting · NCT05674526 · Registry updated 2025-04-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1b Study of WU-NK-101 in Combination With Cetuximab | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Active, not recruiting | Phase 1 | 2025-04-15 | NCT05674526 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Allotera Therapeutics | 3 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Montefiore Medical Center | The Bronx | United States | 198 |
| UCSF | San Francisco | United States | 27 |